Erica Franceschini

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi‐Lepri et al. · The Lancet Rheumatology · 2020 · 997 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +6

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel et al. · Clinical Infectious Diseases · 2018 · 412 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +13

Hypokalemia in Patients with COVID-19

Gaetano Alfano, Annachiara Ferrari, Francesco Fontana et al. · Clinical and Experimental Nephrology · 2021 · 119 citations · Full text

Medicine, Infectious Diseases, Nephrology +5

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality

Ilenia Gatto, Emanuela Biagioni, Irene Coloretti et al. · Intensive Care Medicine · 2022 · 92 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +16

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria

Antonella Santoro, Erica Franceschini, Marianna Meschiari et al. · Open Forum Infectious Diseases · 2020 · 90 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12